Accendra Health (ACH) Cash & Equivalents Growth (3y) (2012 - 2026)
Accendra Health (ACH) Cash & Equivalents Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 160.31% |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -5.28% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 12.24% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -0.44% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 3.08% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 71.45% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | - |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -8.72% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -65.03% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.45% |
| Dec 31, 2025 | 59.52% |
| Sep 30, 2025 | -24.65% |
| Jun 30, 2025 | -12.14% |
| Mar 31, 2025 | -34.48% |
| Dec 31, 2024 | -20.90% |
| Sep 30, 2024 | 4.56% |
| Jun 30, 2024 | 75.05% |
| Mar 31, 2024 | 65.06% |
| Dec 31, 2023 | 43.03% |
| Sep 30, 2023 | 40.70% |
| Jun 30, 2023 | 41.40% |
| Mar 31, 2023 | -10.20% |
| Dec 31, 2022 | 1.20% |
| Sep 30, 2022 | -7.44% |
| Jun 30, 2022 | -14.84% |
| Mar 31, 2022 | 41.09% |
| Dec 31, 2021 | -5.64% |
| Sep 30, 2021 | -31.72% |
| Jun 30, 2021 | -27.29% |